Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA) ...Middle East

HONG KONG, June 8, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, muscle-preserving weight loss drug candidate ASC47 will...

Read More Details
Finally We wish PressBee provided you with enough information of ( Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA) )

Also on site :

• Former student kills 10 people in Austrian high school shooting
• Hollywood Royal, 35, Makes Jaw-Dropping Confession About Taylor Swift's Rock Icon Ex, 36
• U.S., China reach deal to ease export curbs, keep tariff truce alive